药物对比
Acarbose vs Troglitazone
Acarbose（Precose）与Troglitazone（Rezulin，已撤市）对比：α-葡萄糖苷酶抑制剂 vs TZD。Troglitazone因肝毒性于2000年撤市。两者均为口服抗糖尿病药物。
此页面暂无可用的对比维度。
临床背景
This comparison is relevant for historical or educational purposes regarding type 2 diabetes treatments, as Troglitazone is no longer on the market.
结论
Acarbose remains an option for postprandial glucose control while Troglitazone is obsolete due to safety issues.
全部药物对比